Schmerzklinik Kiel Gmbh & Co. KG Klinik fuer neurologisch-verhaltensmedizinische Schmerztherapie

The Schmerzklinik Kiel Gmbh & Co. KG Klinik fuer neurologisch-verhaltensmedizinische Schmerztherapie is conducting clinical trials focused on nervous system diseases, with a strong emphasis on migraine care. The studies mainly address chronic migraine, episodic migraine, and related migraine patterns, aiming to improve prevention, symptom control, and day-to-day disease management.

• Testing new preventive options for chronic migraine and episodic migraine
• Comparing treatments to better understand safety and tolerability in migraine
• Evaluating therapies for faster relief during migraine attacks

Much of the research at this clinic in Kiel is centered on whether emerging therapies can reduce migraine frequency and improve quality of life for people living with recurring headache disorders.

This group of trials explores how well different approaches work in preventing and treating migraine, including both chronic and episodic forms. The research is designed to assess treatment effectiveness, compare options already in use, and identify better ways to reduce the burden of frequent migraine attacks.

• Preventive treatment studies for chronic migraine
• Head-to-head comparisons of migraine therapies
• Studies measuring reductions in monthly migraine days

These trials reflect a practical focus on finding treatments that are not only effective, but also acceptable for long-term use in everyday migraine care.

Another important area of research at the site looks at acute migraine treatment, especially for adults who need fast and reliable relief from migraine pain. The trials are evaluating whether new therapies can improve short-term symptom control and offer an alternative for people who may not be suitable for standard options.

• Assessing rapid pain relief in migraine
• Comparing investigational treatment with placebo
• Supporting better options for patients with migraine attacks with or without aura

By focusing on immediate symptom reduction, this research aims to expand treatment choices for people whose migraines disrupt work, family life, and daily routines.

The site is also involved in studies of newer migraine therapies for people whose symptoms have not responded well to previous preventive treatment. These trials are helping researchers understand whether innovative approaches can offer safer, more effective long-term control of migraine.

• Investigating new preventive therapies for chronic migraine
• Studying options for patients with limited response to earlier treatments
• Evaluating treatment benefit in migraine prevention

This line of research highlights a clear goal: to address persistent migraine symptoms with therapies that may better meet the needs of patients who still struggle despite existing care.